Abstract
The glucagon-like peptide-1 (GLP-1) is an endogenous hormone produced by the L cells in the intestine. It is released in response to the intake of food and intestinal dilatation. It stimulates the pancreatic beta-cell to secrete insulin which is dependent upon ingestion of food. GLP-1 acts to slow down gastric motility and suppress appetite through the GLP-1 receptors in the satiety center
Highlights
The glucagon-like peptide-1 (GLP-1) is an endogenous hormone produced by the L cells in the intestine
GLP-1 acts to slow down gastric motility and suppress appetite through the GLP-1 receptors in the satiety center [1]
It is neutralized by the dipeptidyl peptidase-4 (DPP-4) enzyme very quickly
Summary
The glucagon-like peptide-1 (GLP-1) is an endogenous hormone produced by the L cells in the intestine. It is released in response to the intake of food and intestinal dilatation. It stimulates the pancreatic beta-cell to secrete insulin which is dependent upon ingestion of food. GLP-1 acts to slow down gastric motility and suppress appetite through the GLP-1 receptors in the satiety center [1]. It is neutralized by the dipeptidyl peptidase-4 (DPP-4) enzyme very quickly. Administration (FDA) for use in the management of Type 2 diabetes. In combination with other medicinal products for the treatment of diabetes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have